OSI shares jump on lung cancer study data - Forbes
OSI shares jump on lung cancer study data Forbes, NY - 3 hours ago The companies said the drug stopped the spread of advanced non-small cell lung cancer for significantly longer than a placebo, following treatment with ... Tarceva meets goal in first-line lung cancer trial BusinessWeek Roche's Tarceva delays advance of lung cancer guardian.co.uk Phase III Study (SATURN) Showed Tarceva Improved Progression-Free ... WELT ONLINE MarketWatch - RTT News all 47 news articles |
Post a Comment
You must be logged in to post a comment.